Skip to content

PODOLOGISTICA

Active
Private limited company·Activiteiten op het gebied van kinesitherapie· 5 yrs active
Lammekensstraat 16 ·2390 Malle, Belgium
BE 0759.767.346
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of PODOLOGISTICA is 0.1% (very low). The 2025 annual accounts show equity of €110k and a net result of €49k. Equity is growing by ~27.4% per year across the filed fiscal years. Its solvency ranks better than 42% of 2192 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 6 annual accounts.

Trust signals

3 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€49k-10.8%
Working capital€41k-20.3%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 21-04-2026 with the NBB · fiscal year 2025 · micro
€0€20k€40k€60k€80kOperating result 2021: €36k€36kNet result 2021: €28k€28kOperating result 2022: €49k€49kNet result 2022: €37k€37kOperating result 2023: €32k€32kNet result 2023: €24k€24kOperating result 2024: €75k€75kNet result 2024: €54k€54kOperating result 2025: €67k€67kNet result 2025: €49k€49k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~27.4%/year over 6 fiscal years, indicative, assuming unchanged policy.
€0€100k€200k2026: €150k (€133k - €167k)2027: €174k (€146k - €201k)2028: €197k (€159k - €234k)2020: €7k2021: €35k2022: €72k2023: €97k2024: €104k2025: €110k202020212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 44.4% 58.0%
better than 42% of 2192 sector peers
Net result €49k €60k
better than 42% of 2190 sector peers
Equity €110k €74k
better than 61% of 2192 sector peers
Gross operating margin €80k €96k
better than 43% of 2192 sector peers
Total assets €247k €186k
better than 62% of 2192 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€79k
-6.6% +117% vs sector
Net profit
€49k
-10.8% +178% vs sector
Cash flow
€60k
-6.3% +134% vs sector
Total assets
€247k
+40.2% +35% vs sector
Equity
€110k
+5.3% -25% vs sector
Working capital
€41k
-20.3% -58% vs sector
Income taxes
€17k
-11.5% +166% vs sector
Dividends
€43k
-8.5% -45% vs sector
Debt
€137k
+90.7% +275% vs sector
Debt ≤ 1y
€60k
+225.5% +64% vs sector
Debt > 1y
€75k
+42.8% far above sector median
Current ratio
1.69
-55.8% -11% vs sector
Quick ratio
1.69
-55.8% -11% vs sector
Solvency
44.4%
-24.9% -36% vs sector
Debt / equity
1.25
+81.0% +188% vs sector
ROE
44.3%
-15.3% far above sector median
ROA
19.7%
-36.4% far above sector median
Interest coverage
36.94
-22.3% -2% vs sector
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€79k
Net profit€49k
Cash flow€60k
Staff costs-
Income taxes€17k
Dividends€43k
Total assets€247k
Equity€110k
Debt€137k
of which ≤ 1y€60k
of which > 1y€75k
Working capital€41k
Employees (FTE)-
Ratios (computed)
2025
Current ratio1.69
Quick ratio1.69
Working capital ratio16.8%
Solvency44.4%
Debt / equity1.25
Long-term debt ratio0.69
Interest coverage36.94
Gross margin-
Net margin-
ROA19.7%
ROE44.3%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€247k
Fixed assets 21/28€145k
Tangible fixed assets 22/27€145k
Financial fixed assets 28€900
Current assets 29/58€101k
Amounts receivable within one year 40/41€7k
Cash & bank 54/58€80k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€247k
Equity 10/15€110k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€107k
Amounts payable 17/49€137k
Amounts payable after one year 17€75k
Amounts payable within one year 42/48€60k
Trade debts payable within one year 44€798
Income statement
Gross operating margin 9900€80k
Operating result 9901€67k
Financial income 75€694
Financial charges 65€2k
Result before taxes 9903€66k
Income taxes 67/77€17k
Net result for the period 9904€49k
Result to be appropriated 9905€49k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
86 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
PODOLOGISTICA
Lammekensstraat 16, 2390 MallePodologie activiteiten
since 20202.310.916.914
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area778 m²
Buildings1
Building footprint120 m²
Volume (LiDAR)671 m³
Tallest building10.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11049A0429/00K002 Flanders 778 m² 1 · 119 m² 10.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health86Profitability100Solvency82Growth78Stability94
88 / 100

Exceptional profile, strong across almost every axis.

Health 86
Profitability 100
Solvency 82
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Ambulante revalidatieactiviteiten86905Activiteiten op het gebied van kinesitherapie86951
Primary activity highlighted.
Names & trade names
Legal nameNL PODOLOGISTICA
Registered office
Lammekensstraat 16
2390 Malle, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.